We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Argent Biopharma packs its bags for London on a one-way ticket Patrys shares slump 50% on cancellat...
Read ArticleArgent Biopharma plans further trials of its cannabinoid-based epilepsy treatment Argent’s early r...
Read ArticleMGC Pharmaceuticals has officially rebranded to Argent BioPharma Strategic renaming follows infusio...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleMGC Pharmaceuticals completes share consolidation, ~US$8 million capital raise Company says it’s fu...
Read ArticleMGC Pharmaceuticals secures US$7.9 million in firm commitments in well supported capital raise Fund...
Read ArticleThe S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% f...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleBenchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, produced in something of a grumbly mood this morning af...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, published after I’ve had a chance to look over the numb...
Read ArticleSeveral ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
Read ArticleStockhead’s Top 10 at shortly-before-11-ish, published once you’re all sitting nice and quietly each...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleStockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe US is about to follow Australia’s footsteps and approve psychedelics The FDA is currently await...
Read ArticlePositive results from pre-clinical chronic toxicology evaluation of MGC Pharma’s CimetrA® in pigs su...
Read ArticleAnteris Tech’s DurAVR THV was implanted successfully in a procedure Imugene moves forward to cohort...
Read ArticleMGC Pharmaceuticals has secured the first import permit for 200g of psilocybin raw mushroom material...
Read ArticleWhat a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial yea...
Read ArticleMGC Pharmaceuticals has conditionally raised £0.65 million ($1.24 million) via a placement and subsc...
Read ArticleMGC Pharma has received a vote of confidence in ArtemiC after receiving a second order worth US$1m f...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosiv...
Read ArticleMGC Pharmaceuticals’ Investigational Medicinal Product (IMP) CannEpil has been successfully imported...
Read ArticleShareCafeASX closes 1.2% lower as RBA hikes rates by 25 basis points by Peter Milios Following the...
Read ArticleShareCafeQantas hires a new CEO: ASX down 0.22% at noon by Peter Milios At noon, the S&P/ASX 2...
Read Article02 May 2023 - A snapshot of the stocks on the move featuring MGC Pharmaceuticals (ASX:MXC), Vitura H...
Read ArticleMGC Pharma’s recently-acquired EU-Good Manufacturing Practice (GMP) certification will allow the co...
Read ArticleShareCafeStocks of the Hour: MXC, VIT, LRL MGC Pharmaceuticals (ASX:MXC) an...
Read ArticleMGC Pharma says the breakthrough in the UK will allow CannEpil to be made available to a wide cohort...
Read ArticlePost-Easter burst of zeal sees the ASX 200 up 1.3% at close Materials (+2.1%) outperformed by conti...
Read ArticleThe number of Aussies using legal instead of illicit medical cannabis is rising The main reason for...
Read ArticleThe approval in Slovenia will allow MGC Pharma to become one of the first movers in the burgeoning s...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX climbed as high as +1.3%, easing slightly to close up 0.9%. XEC Emerging Companies and Goldies...
Read ArticleShareCafeRebound in financial stocks boosts ASX 0.82% by Peter Milios The sharemarket had a positi...
Read Article21 Mar 2023 - A snapshot of the stocks on the move featuring Besra Gold (ASX:BEZ), Mincor Resources...
Read ArticleFirebrick Pharma reopens recruitment for Phase 3 trial MGC Pharma given OTC status in FDA’s NDC dat...
Read ArticleShareCafeASX up 1.3% at noon as UBS makes large forecasts by Peter Milios According to UBS analyst...
Read ArticleShareCafeStocks of the Hour: BEZ, MCR, MXC, RNX Besra Gold (ASX:BEZ) has an...
Read ArticleThe inclusion of MGC Pharma’s ArtemiC into the FDA’s NDC database will fill an important hole in the...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticlePerth-based Brookside Energy (BRK) has delivered “extraordinary” early production and sales results...
Read ArticleShareCafeBig gains from Tech push ASX 0.86% higher by Peter Milios The Australian stock market exp...
Read ArticleShareCafeASX up 0.29% at noon on the back of big gains in Tech by Peter Milios The Australian stoc...
Read ArticleShareCafeStocks of the Hour: REC, MXC, SOP Recharge Metals (ASX:REC) has en...
Read Article15 Mar 2023 - A snapshot of the stocks on the move featuring Recharge Metals (ASX:REC), MGC Pharmace...
Read ArticleMGC Pharmaceuticals (MXC) completes its in-vitro pre-clinical study on its anti-inflammatory test dr...
Read ArticleEmyria partners with PAX to provide safe MDMA-based psychedelics therapy for PTSD MGC Pharma conclu...
Read ArticleMGC Pharma completes pre-clinical study on CimetrA Recce Pharma close to getting Aussie patent AdAl...
Read ArticleThe ASX is poised to open higher on the first day of 2023 Wall Street had one of its worst years in...
Read ArticleNSB files new patent in Australia Imugene doses first patient in Phase 1 trial Cronos and MGC Pharm...
Read ArticleThe ASX is set to rise on Monday Wall Street finished mixed after a strong jobs report lifted the r...
Read ArticleAussie market delivers a rock-solid mediocre effort Koba Resources hits the jackpot by hammering so...
Read ArticleThe ASX 200 starts the week with a bang Materials surge has investors beaming China learns a brutal...
Read ArticleThree medicinal cannabis companies — two of which are based in WA — have been hit with fines totalli...
Read ArticleWhile early days, MGC Pharmaceuticals is encouraged by interim results in the CimetrA dose finding s...
Read ArticleResearchers say data shows transition from illicit to legal use of cannabis Medicinal users are at...
Read ArticleMGC Pharmaceuticals (MXC) receives a US$1 million (A$1.43 million) order for its anti-inflammatory...
Read ArticleThe ASX200 is riding Wall Street’s coattails today up 044% Nine out of eleven sectors were higher,...
Read ArticleIce-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm le...
Read ArticleMGC Pharma believes ZAM is a game-changer and has the possibility of personalising medication – not...
Read ArticleInvestors have reacted positively to news MGC Pharma’s ArtemiC has shown promise in treating Long Co...
Read ArticleMGC Pharmaceuticals (MXC) receives study and import approvals from the South African Health Product...
Read ArticleMGC Pharma to go Phase 2 on COVID-19 in South Africa Neurotech says cannabis strain works well in c...
Read ArticleMGC Pharmaceuticals (ASX:MXC) has provided an update on its pre-clinical in vitro study of C...
Read ArticleMGC Pharmaceuticals (MXC) indicates CimetrA has a wide-ranging application as an anti-inflammatory...
Read ArticleMGC Pharma is working to provide treatment hope for one of the most common and aggressive forms of b...
Read ArticleA Thai university says adding cannabis to chicken feed has positive results on meat and egg quality...
Read ArticleMGC Pharmaceuticals (MXC) completes a successful in-vitro preclinical research study in the use of...
Read ArticleEmerging Companies (XEC) index jumps more than 2% before trimming gains Benchmark ASX200 down 0.1...
Read ArticleActor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wel...
Read ArticleMGC Pharmaceuticals (MXC) has been granted a patent from the Slovenian Intellectual Property Office...
Read ArticleLONDON, April 5, 2022 /PRNewswire/ – MGC Pharmaceuticals Ltd. (LSE: MXC, ASX: MXC, OTC:MGCLF), a...
Read ArticleV-Con is Stockhead’s investing focused video conference series, bringing you expert insights, panel...
Read ArticleMGC Pharma has just delivered its best half ever, as it looks to complete a pipeline of clinical tri...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.55% at the time of writing, compared to the br...
Read ArticleSales amounted to US$1.8mln in the fourth quarter, with COVID-19 treatment ArtemiC accounting for 60...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price smoked the market today. This comes after the co...
Read ArticleThe ASX has recovered following yesterday’s strong blow, closing up 1.29% with all 11 sectors finish...
Read ArticleMGC Pharmaceuticals (MXC) receives an import approval permit for its COVID-19 treatment product, Ar...
Read ArticleManaging director Roby Zomer says MGC is “pleased to have the opportunity to alleviate the symptoms...
Read ArticleIt’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19...
Read ArticleIt’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19...
Read ArticleIt’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19...
Read ArticleMGC Pharmaceuticals (MXC) begins a clinical study on patients with Long COVID syndrome in Spain MGC...
Read ArticleIt’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19...
Read ArticleSwiss PharmaCan and Glow LifeTech are carrying out the research which should be complete in February
Read ArticleThe TGA nod is the first ever in Australia. A breakthrough which gives MGC Pharma partner EXTRAX cre...
Read ArticleIt said it plans to begin the approval process for CimetrA in India before rolling it out to a total...
Read ArticleThe ASX returned to positive territory today as investors began to shrug off fears of the omicron va...
Read ArticleMGC Pharmaceuticals (MXC) places its shares in a trading halt while it plans the details of an upco...
Read ArticleMGC Pharmaceuticals (MXC) completes production of the €650,000 (A$1.01 million) ArtemiC order from...
Read Article“With the continuing outbreaks of COVID-19, not only in Europe but globally, we expect to see contin...
Read ArticleThe US$750k received today is just the first part of the US$24m three-year agreement with US distrib...
Read ArticleThe bio-pharma group also announced that AMC has engaged Morgan Lewis & Bockius, a leading US ph...
Read ArticleHighlights Cannabis-based medicine and products businesses have expanded significantly in the pa...
Read ArticleMGC Pharmaceuticals (MXC) completes the construction phase of the CimetrA production facility in Ma...
Read ArticleThe new facility in Malta sets MGC Pharma up to meet the rapidly increasing demand for its COVID-19...
Read ArticleThe company is now moving onto the equipment fit-out and commissioning phase
Read ArticleMGC Pharmaceuticals (MXC) sees the Israeli Ministry of Health grant approval for a global dosing s...
Read ArticleIntelicare nabs MercyCare contract for its AI sensor tech Telix scores TGA approval for prostate ca...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is shooting higher and is currently up around 2%...
Read ArticleThe Israeli authorities will oversee the study, which will involve 240 people in three countries
Read ArticleMGC Pharma’s Q1 results saw the company continue to build strong foundations for future growth. Eur...
Read ArticleThe latest quarter delivered nearly US$1mln of cash receipts and US$564,000 of Phytocannabinoid medi...
Read ArticleEarly prevention of cytokine storm appears to be an effective method of treatment in mild and modera...
Read ArticleMGC Pharma has secured its biggest order for any product with its US distributor AMC Holdings confid...
Read ArticleThe US$3mln purchase order is for CimetrA, MGC’s curcumin and Boswellia compound, which has shown ea...
Read ArticleThe units were ordered to fast track the approval process for the medication to be distributed and s...
Read ArticleThe initial order in the US is expected to fast track the regulatory approval for CimetrA, and estab...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is clicking higher on Thursday and is currently...
Read ArticleShareCafeAustralia… One Hour In… ASX200 up 61 ASX200 up 61 points (0.8%) to 7258. Commonwealth Ba...
Read ArticleThe order of 1,000 units of CimetrA is part of a landmark deal with AMC worth a minimum of US$24mln
Read ArticleThe order of 1,000 units of CimetrA is part of a landmark deal with AMC worth a minimum of US$24mln
Read ArticleThe research note out of fundie Canaccord says that MGC Pharma has several tailwinds, including near...
Read ArticleIn major milestones, MGC Pharma’s non-cannabis products ArtemiC and CimetrA got further boosts today...
Read ArticleThe ASX 200 health stocks index (XHJ) has lifted by 0.46% at the time of writing, compared to the br...
Read ArticleWednesday's statement brought two significant developments for the ArtemiC product group
Read ArticleMGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still un...
Read ArticleEurope-based biotech MGC Pharma has achieved a major milestone in its treatment of refractory epilep...
Read ArticleMGC Pharmaceuticals Ltd is up 11.67% having achieved a new landmark for the UK cannabis market as Ca...
Read ArticleThe ASX 200 health stocks index (XHJ) fell by 0.90% at the time of writing, compared to the broader...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is charging higher on Tuesday. In early trade, t...
Read ArticleWall Street snaps four-day losing streak In US stock markets, the S&P 500 rose by 0.23% and the...
Read ArticleCannEpil+ will be made available for free on compassionate grounds to ten patients with refractory e...
Read ArticleThe Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused dr...
Read ArticleNeurological disorder specialist, Neuroscientific Biopharma (ASX:NSB), announced that research work...
Read ArticleMGC Pharma has been given the green light to import its lead product CimetrA into India in a crucial...
Read ArticleRevenues in the year to end June 2021 rose 43% with phytocannabanoid sales up 69%
Read ArticleMGC Pharma has a growing patient base in Australia, the UK, Brazil and Ireland and has a global dist...
Read ArticleMGC Pharma has a growing patient base in Australia, the UK, Brazil and Ireland and has a global dist...
Read ArticleHot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger compa...
Read ArticleThe ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday...
Read ArticleMGC Pharmaceuticals Ltd has been a huge winner today, up 43.59%. MXC has signed a landmark deal with...
Read ArticleShares in Perth-listed MGC Pharmaceuticals have surged after the company announced it has secured a...
Read ArticleHighlights Emyria has entered into a Master Services Agreement with Calvert Labs, a leading Nort...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price has bolted more than 40% higher in morning trade...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleWall Street snaps three-day gain streak All three US stock market indexes fell last night, and snapp...
Read ArticleThe phytomedicine group has been the top riser in London on Thursday
Read ArticleEuropean-based biopharma company MGC Pharma (ASX:MXC) has delivered its strongest quarterly sales to...
Read ArticleStockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly resu...
Read ArticleWall Street rises ahead of Fed Reserve decision All three major US benchmarks rose modestly on Monda...
Read ArticleThe company's co-founder Roby Zomer said the results meant the group "remains on a strong operationa...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read Article"The acceptance of this patent could be transformational for patients who need treatment and therape...
Read ArticleSummary Kirkland (ASX:KLA) reports record production in second quarter 2021 Finbar (ASX:FRI) ri...
Read ArticleMGC Pharmaceuticals (ASX:MXC) has announced that the phase 3 clinical trial evaluating the e...
Read ArticleCimetrA will be used to treat hospitalised Covide patients
Read ArticleCannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Me...
Read ArticleThe US cannabis sector received a big lift after Amazon announced that job applicants at its offices...
Read ArticleThe MGC Pharmaceuticals [ASX:MXC] cannabis-derived epilepsy product is set to be fully covered by th...
Read ArticleA product formulated by MGC Pharmaceuticals that combats drug-resistant epilepsy will be fully subsi...
Read ArticleEuropean-based biopharma company MGC Pharmaceuticals (ASX:MXC) has announced that its epilepsy drug,...
Read ArticleThe European-based company develops and supplies affordable standardised phytocannabinoid-derived me...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA glance at some of the day's highlights from the Proactive Investors newswire
Read ArticleMGC Pharmaceuticals says it continues to advance separate clinical trial programs looking to tackle...
Read ArticleAll three trials are well funded, following the successful £6.5 million IPO fundraising and listing...
Read ArticleEuropean-based biopharma company MGC Pharmaceuticals (ASX:MXC) has continued to make progress on its...
Read ArticleMGC Pharmaceuticals says a patent application for its CimetrA investigational medical product filed...
Read ArticleCimetrATM has been designed for multiple therapeutic applications including acute and chronic inflam...
Read ArticleLBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample anal...
Read ArticleEuropean-based biopharma company MGC Pharmaceuticals (ASX:MXC) has just announced major progress in...
Read ArticleThe bio-pharma firm said it expects the patent to be issued from the Slovenian Intellectual Property...
Read ArticleSummary The benchmark index was up today, with most of the indices trading in the green zone. a...
Read ArticleThere was shock and confusion in the North American cannabis industry last week, after news broke th...
Read ArticleMGC Pharmaceuticals appears to have delivered a breakthrough in its ArtemiC Rescue supplement’s abil...
Read ArticleEuropean-based biopharma company MGC Pharmaceuticals (ASX:MXC) has just announced exciting further r...
Read ArticleThe mechanism of action of ArtemiC is focused on the anti-inflammatory effect and prevention of cyto...
Read ArticleThe ASX 200 has rebounded from yesterday’s loss though the technology sector has weighed on the mark...
Read ArticleThe ASX finished the day in the red and the tech sector dropped more than any other sector. The ASX...
Read ArticleIts securities will remain halted until the start of normal trading on Monday, May 10, 2021, or unti...
Read ArticleSummary The increase in the level of digitisation has led to a rise in the number of scams in Au...
Read ArticleMGC Pharmaceuticals has secured a $1 million order for its COVID-19 supplement ArtemiC Rescue from n...
Read ArticlePhase 2 trials have shown ArtemiC’s ability to reduce symptoms and pain associated with COVID-19 and...
Read ArticleEuropean-based biopharma company MGC Pharmaceuticals (ASX:MXC) has just received $1 million worth of...
Read ArticleSummary 5G Networks reported robust growth across all three core products in Q3 FY21 and witness...
Read ArticleSummary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookin...
Read ArticleSummary MGC Pharmaceuticals rallied by 8.7% to A$0.062 as its Canada-based North American distri...
Read ArticleThe ASX-listed bio-pharma company’s Canadian distribution partner — which it collaborated with to cr...
Read ArticleGlow LifeTech has exclusive rights to market, sell and distribute ArtemiC™ in Canada, USA, Mexico an...
Read ArticleSummary Respiri Limited has partnered with Australia’s largest pharmacy network, TerryWhite Chem...
Read ArticleMGC Pharmaceuticals Ltd (ASX: MXC) is one to watch this afternoon. The MGC Pharma share price has c...
Read ArticleSummary Several ASX-listed companies have released their quarterly results in the last few days,...
Read ArticleSummary Medicinal cannabis player MGC Pharmaceuticals has a historic quarter with the ground-bre...
Read ArticleMGC Pharma became the first medicinal cannabis company to list on the London Stock Exchange, amid re...
Read ArticleSummary Drug discovery company developing new therapies, Dimerix, has enrolled multiple patients...
Read ArticleSummary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight foll...
Read ArticleASX-listed MGC Pharmaceuticals has snapped up clinical and medical research company MediCaNL which w...
Read ArticleMGC Pharma to bring clinical trials research company MediCaNL’s services in-house Transaction is fo...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is soaring today after news the company will acq...
Read ArticleThe acquisition leverages the medical research expertise in-house which will reduce preclinical lead...
Read ArticleSummary Health House International has signed a non-exclusive distribution agreement with Dragon...
Read ArticleSource: photolona, Shutterstock Summary Australian Primary Hemp has signed another retail distr...
Read ArticleMGC Pharma, which has three investigational medical products in three clinical trials, has reported...
Read ArticleThe number of medical cannabis prescriptions issued under Australia’s special access scheme just kee...
Read ArticleASX and LSE-listed MGC Pharmaceuticals has banked a record $880,000 in quarterly revenue from sales...
Read ArticleSource: DG PhotoStock, Shutterstock Summary ASX-cannabis player Bod Australia has obtained a bi...
Read ArticleMedicinal cannabis biotech company MGC Pharmaceuticals (ASX:MXC) has delivered the first batch of pu...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is off to the races today, up 13% at the time of...
Read ArticleBio-pharma company, MGC Pharmaceuticals has received ethics committee approval from two Israeli hosp...
Read ArticleSource: create jobs 51, Shutterstock Summary MGC Pharmaceuticals has received approval from the...
Read ArticleMGC Pharmaceuticals (ASX: MXC) shares are on the rise today after the company advised two ethics co...
Read ArticleMedicinal cannabis biotech company MGC Pharmaceuticals (ASX:MXC) can proceed to a Phase III clinical...
Read ArticleThe North American cannabis market received a huge shakeup this week, after British American Tobacco...
Read ArticlePot legalisation is creeping across the US state by state, and a major market could be about to join...
Read ArticleSource: Stereo Lights, Shutterstock Summary The Australian cannabis industry is in an infant st...
Read ArticleSource: ITTIGallery ,Shutterstock Summary Metalstech’s share price has shot up by 45.8 per cent...
Read ArticleBio-pharma group MGC Pharmaceuticals has received a much larger initial purchase order from European...
Read ArticleThe MGC Pharmaceuticals Ltd [ASX:MXC] share price is up after its leading European distributor incre...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is gaining today, up 2.5% in late morning trade....
Read ArticleSource: metamorworks,Shutterstock Summary MGC Pharmaceuticals has received an increased purchas...
Read Article"This further agreement will provide more people access to the natural therapeutic benefits of the s...
Read ArticleMilestones during the period included an acquisition, first product shipments, expansion of manufact...
Read ArticleSource: Shutterstock Summary Fast-paced economic recovery seems to be driving the popularity of...
Read ArticleStockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical ga...
Read ArticleIt’s been a dismal day for the market, although small-cap investors can perhaps take some measure of...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price zoomed up more than 35% higher today off the bac...
Read ArticleThe company is also carrying out clinical trials of ArtemiC into the treatment of COVID-19
Read ArticleThe company has signed a minimum three-year exclusive worldwide supply and distribution agreement wi...
Read ArticleSummary European based bio-pharma player MGC Pharmaceuticals has entered into an exclusive world...
Read ArticleLondon's cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutan...
Read ArticleMGC Pharmaceuticals and Kanabo Group have both had a warm welcome after listing this month
Read ArticleLondon Stock Exchange-listed MGC Pharma expands brain cancer treatment research ‘Importantly, we are...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price has been smoking the market on Wednesday. In aft...
Read ArticleSummary The cash net profit after tax for Commonwealth Bank of Australia stood at A$3.89 billion...
Read ArticleThe medicinal cannabis developer was valued at £33.7mln on London debut
Read ArticleThe medicinal cannabis developer was valued at £33.7mln on London debut
Read ArticleSummary Several ASX- listed companies are under the spotlight amid ongoing reporting season. Th...
Read ArticleDespite shying away from the limelight again recently, pot stocks continue to make ground. With seve...
Read ArticleSummary European biopharma company MGC Pharmaceuticals is on the verge of getting listed on the...
Read ArticleMGC Pharma will maintain a dual LSE and ASX listing to significantly broaden the company’s internati...
Read ArticleThe company is confident of a continued increasing trend of MGC Pharma unit sales and new patient gr...
Read ArticleThe company is focused on its core business of executing its growth strategy and become a world-lead...
Read ArticleThe company is focused on its core business of executing its growth strategy and become a world-lead...
Read ArticleThe new sales director has held senior sales and business development positions at multi-national he...
Read ArticleThe proposed European Union GMP-compliant facility will be able to produce 10,000 units of liquid do...
Read ArticleShares in ASX-listed MGC Pharmaceuticals shot out of the blocks in opening trades on Tuesday followi...
Read ArticleAt the time of writing, the share price of MGC Pharmaceuticals Ltd [ASX:MXC] is flat, trading at 3.2...
Read ArticleSummary EU biopharma player MGC Pharmaceuticals completed Phase II clinical trial of ArtemiCTM i...
Read ArticleBiopharma company MGC Pharmaceuticals (ASX:MXC) has confirmed the successful results of its second p...
Read ArticleASX-listed medicinal cannabis player, MGC Pharmaceuticals, expects results in the next few days from...
Read ArticleIn anticipation of the trial results, the company is working on the reclassification of ArtemiC from...
Read ArticleThe company's flagship phytomedicines will now have far fewer obstacles to overcome as they work tow...
Read ArticleThe company will use the funds from the sale as working capital to fund its core strategy to be a fu...
Read ArticleNew joint company secretary Narelle Warren has coordinated and assisted in numerous corporate transa...
Read ArticleThe drawdown will be provided through the issue of 3.85 million convertible notes with a face value...
Read ArticleSince 2019, Medicinal Cannabis Clinics has facilitated over 4,000 medical consultations with pre-scr...
Read ArticleASX-listed MGC Pharmaceuticals has received more successful results from its proprietary medical res...
Read ArticleASX-listed MGC Pharmaceuticals has received more successful results from its proprietary medical res...
Read ArticleThe company has developed a formulation of cannabidiol and cannabigerol that is proving effective in...
Read ArticleAs the second wave of Coronavirus cases continue to wash across the globe, MGC Pharmaceuticals has j...
Read ArticleAs the second wave of Coronavirus cases continue to wash across the globe, MGC Pharmaceuticals has j...
Read ArticleThe European-based biopharma company believes positive trial results have the potential to deliver m...
Read ArticleSummary Therapeutic Goods Administration (TGA) has decided to alter the present Poisons Standard...
Read ArticleASX-listed and medicinal marijuana group, MGC Pharmaceuticals, has achieved record weekly sales grow...
Read ArticleIs the pot stock boom back? That is the question that investors need to be asking themselves right n...
Read ArticleIt is well on track to achieving record sales for the December quarter with strong domestic order pi...
Read ArticleSecond-stage safety and toxicity tests for MGC Pharmaceuticals’ (ASX:MXC) anti-inflammatory cannabin...
Read ArticleResults provide critical additional information on the toxicological evaluation of ArtemiC regarding...
Read ArticleMedicinal marijuana group, MGC Pharmaceuticals, has successfully shipped its first tetrahydrocannabi...
Read ArticleMGC Pharmaceuticals (ASX:MXC) has shipped its Mercury Pharma THC cannabinoid products to Brazil for...
Read ArticleBrazil is a strategically important market with a population of over 210 million and a pharmaceutica...
Read ArticleMedicinal marijuana group, MGC Pharmaceuticals, has launched a patient information app for its epile...
Read ArticleAt the time of writing, shares of MGC Pharmaceuticals Ltd [ASX:MXC] are up 4.55% to trade at 2.3 cen...
Read ArticleThe app will record patient responses to medical questionnaires and the treating practitioner will b...
Read ArticleThe number of new patients trying medicinal cannabis for the first time has risen significantly sinc...
Read ArticleAs the second wave of Coronavirus cases grips the world, MGC Pharmaceuticals is expanding the Phase...
Read ArticleThe company recently announced the interim results of the trial met all primary endpoints for the sa...
Read ArticleMGC Pharmaceuticals (ASX:MXC) says it has recruited 33 of the 50 COVID-19 patients it needs for its...
Read ArticleASX-listed MGC Pharmaceuticals’ hopes of becoming one of the first medicinal marijuana companies to...
Read ArticleThe company has welcomed a new guidance note from the FCA and is confident it meets the requirements...
Read ArticleThe Australian operations of MGC Pharmaceuticals have been given a potential boost following the rec...
Read ArticleThe Therapeutic Goods Administration has confirmed its intention to down schedule certain low-dose m...
Read ArticleASX-listed MGC Pharmaceuticals has struck a significant funding deal with US-based investment group,...
Read ArticleThe first tranche of the $2.25 million financing will be provided shortly through the issue of 2,475...
Read ArticleASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re...
Read ArticleA US investment group has agreed to provide medical cannabis company MGC Pharmaceuticals (ASX:MXC) w...
Read ArticleThe halt will remain in place until the start of trading on Thursday, September 10, or when an anno...
Read ArticleEuropean biopharma company MGC Pharmaceuticals (ASX:MXC) has bolstered its team of directors with th...
Read ArticleThe new appointments ensure the company is well-placed to deliver on its strategy to become a leadin...
Read ArticleMGC Pharmaceuticals’ continued success in clinical trial tests on COVID-19 patients has seen the com...
Read ArticleThe proposed joint venture company will be managed by Dr Kopachevskaja and her team with assistance...
Read ArticleMGC Pharma (ASX:MXC) has established a joint venture for medical products in the Russian market incl...
Read ArticleASX-listed medicinal marijuana company, MGC Pharmaceuticals’ natural supplement “ArtemiC” has emerge...
Read ArticleResults met FDA primary endpoint of sustained clinical recovery, preventing the need of intensive ca...
Read ArticleThe European-based biopharma company recently received an initial purchase order from LYPHE for 900...
Read ArticleASX-listed medicinal cannabis player, MGC Pharmaceuticals, has snared a key UK distribution agreemen...
Read ArticleThe European-based biopharma company has already received an initial purchase order from LYPHE for 9...
Read ArticleThe company is developing medicines that leverage its proprietary medicinal cannabis formula through...
Read ArticleThe webinar will also be live-streamed on the Proactive YouTube channel, which can then be viewed at...
Read ArticleStockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment...
Read ArticleBio-pharma company MGC Pharmaceuticals’ natural supplement “ArtemiC” may end up helping in the globa...
Read ArticleSome elements of the formulation demonstrated an effective response on immune function in a manner c...
Read ArticleSome elements of the formulation demonstrated an effective response on immune function in a manner c...
Read ArticleNews that MGC Pharmaceuticals’ (ASX:MXC) phytocannabinoid-derived medical spray could be an effectiv...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleArtemiC is a natural supplement formula based on Artemisinin and Curcumin, along with supporting ing...
Read ArticleSummary EU biopharma player MGC Pharmaceuticals announced favourable safety and tolerability resu...
Read ArticleSummary EU biopharma player MGC Pharmaceuticals announced favourable safety and tolerability resu...
Read ArticleThe results follow a pre-clinical study undertaken on nine mice in Israel, with ArtemiC delivering n...
Read ArticleMGC Pharmaceuticals (ASX:MXC) has achieved positive safety and efficacy results from a safety and to...
Read ArticleThe company creates premium phytocannabinoid-based products from its GMP facility in Europe that can...
Read ArticleIt’s been a while since pot stocks have made headlines. The industry as a whole has been fairly qui...
Read ArticleMedicinal Cannabis Clinic provides a range of solutions focused on enabling patient access to afford...
Read ArticleBio-pharma company MGC Pharmaceuticals (ASX:MXC) has struck a $1.4m deal to acquire Australian clini...
Read ArticleSummary MGC Pharmaceuticals received a cannabis research cultivation permit, allowing the company...
Read ArticleMGC Pharmaceuticals continues to kick goals in the medicinal cannabis space in Australia, having cli...
Read ArticleThis permit enables the company to proceed with its botanical research projects in collaboration wit...
Read ArticleMGC Pharmaceuticals (ASX: MXC) has reached yet another regulatory milestone after the biopharmaceuti...
Read ArticleOne of Australia's top cannabis companies has today received a Cannabis Research Cultivation Permit,...
Read ArticleMGC Pharmaceuticals (ASX:MXC) has been granted a Cannabis Research Permit from the Australian Office...
Read ArticleThe company creates premium phytocannabinoid-based products from its GMP facility in Europe that can...
Read ArticleSummary Althea announced the commencement of online sales of medicinal cannabis-based products vi...
Read ArticleMedicinal cannabis producer and developer MGC Pharma (ASX: MXC) will see its logistics processes str...
Read ArticleThe licence allows for the importation of any MGC Pharma Schedule-4 and Schedule-8 medicinal cannabi...
Read ArticleThe trial expansion will provide wider statistical data required for the application of marketing au...
Read ArticleMGC Pharmaceuticals (ASX: MXC) has confirmed the footprint of a Phase II trial into the efficacy of...
Read ArticleThe licence reinforces MGC Pharma's ability to deliver on its target production of 5,000 units per m...
Read ArticleOnassis is led by highly experienced entrepreneur Eliron Yaron who has decades of capital markets ex...
Read ArticleEurope-based bio-pharma company MGC Pharma (ASX:MXC) has completed a deal to sell its MGC Nutraceuti...
Read ArticleMGC Pharma secures a second international partnership, signing a binding term sheet. Europe-based bi...
Read ArticleIM Cannabis Corp will be responsible for the importation, commercialisation, promotion and distribut...
Read ArticleOptimism is returning to the sleep apnoea market as Somnomed (ASX:SOM) says the nightmares that prom...
Read ArticleNorth American pot stocks are roaring back from lows in March but the same cannot be said for their...
Read ArticleTHC Global Group (ASX: THC) will pay $3 million in shares and cash to acquire the Tetra Health netwo...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleMedicinal cannabis company MGC Pharma (ASX:MXC) is staying busy during the pandemic, after getting e...
Read ArticleMGC Pharmaceuticals (ASX: MXC) is about to kick-off a phase II clinical trial evaluating a natural a...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleSpecial Report: The upgraded deal is strong confirmation of MGC Pharma’s ability to execute on build...
Read ArticleThere are ASX small caps addressing brain problems and stocks seeking to test cannabis for medicinal...
Read ArticleAs market watchers would know, cannabis stocks globally have had a wild ride over the last three yea...
Read ArticleSpecial Report: Prescription numbers surge as MGC Pharma finds its footing in the global cannabis ma...
Read ArticleThe THC Global Group Ltd (ASX: THC) share price has just finished the week on a high. On Friday the...
Read ArticleMGC Pharmaceuticals has a new agreement with Anden Bio Naturals to produce and supply white labelled...
Read ArticleMGC Pharma (MXC) is set to enlarge its footprint in Latin America after entering a distribution agr...
Read ArticleSpecial Report: The deal with THC Global (ASX:THC) is evidence of the demand for MGC products in the...
Read ArticleMGC Pharmaceuticals has a new agreement in place with THC Global to produce and supply white labelle...
Read ArticleHot on the heels of a new partnership with MGC Pharma (ASX: MXC) THC Global (ASX: THC) has received...
Read ArticleTHC Global (THC) has signed a supply agreement with MGC Pharmaceuticals (MXC) for its medicinal can...
Read ArticleMedicinal cannabis companies THC Global (ASX: THC) and Europe-based, Australian-listed MGC Pharma (A...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price is starting the week on a high. In morning trade...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong g...
Read ArticleMGC Pharmaceuticals (MXC) has passed 2000 prescribed units of its cannabinoid medicines The increa...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a strong performer on Thursday. In morn...
Read ArticleMGC Pharmaceuticals has unveiled a new medicinal cannabis-based line for Australian and New Zealand...
Read ArticleSpecial Report: MGC Pharma is launching a new line of medical cannabis products in order to target a...
Read ArticleMGC Pharmaceuticals (MXC) has launched its new “Mercury Pharma” medicinal cannabis brand The first...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price has returned from its trading halt and rocketed higher. I...
Read ArticleMarijuana is the hottest herb on the planet right now, but while investing in medical cannabis stock...
Read ArticleThere is a lot of optimism surrounding the outlook for the multi-billion-dollar global cannabis indu...
Read ArticleMGC Pharmaceuticals will start phase two ‘b’ clinical trials for its “CogniCann” medicinal cannabis...
Read ArticleMGC Pharmaceuticals’ (MXC) first bulk shipment of CogniCann is en route to Australia and will arriv...
Read ArticleSecurities of MGC Pharmaceuticals Ltd (ASX: MXC) were removed from the restricted list of BNY Mellon...
Read ArticleMGC Pharmaceuticals has surpassed 1,800 prescriptions delivered for its medical cannabis-based produ...
Read ArticleMGC Pharma (MXC) has now prescribed 1800 patients with its cannabis-based medicines This is an incr...
Read ArticleMGC Pharmaceuticals Ltd (ASX: MXC) announced that it has reached more than 1,800 prescriptions of it...
Read ArticleMoney Talks is Stockhead’s regular drill down into what stocks investors are looking at right now. W...
Read ArticleEmerging or early-stage companies offer new investment opportunities to investors, and higher return...
Read ArticleA significant progress has been seen in Cannabis industry at a global scale, a sector that has witne...
Read ArticleSpecial Report: Cannabis stock MGC Pharma will start its European tour in Big Pharma favourite Irela...
Read ArticleIn Australia, medical cannabis is regulated by the Australian Government through the Therapeutic Goo...
Read ArticleIt has been a very disappointing day of trade for the S&P/ASX 200 index on Tuesday. In afternoo...
Read ArticleCannabis space is evolving at a rapid pace with Cannabis legalisation changing the landscape across...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price has been a positive performer on Tuesday. In mor...
Read ArticleMGC Pharmaceuticals has joined Brazil’s leading merchant bank in its quest to conquer Latin America’...
Read ArticleMGC Pharmaceuticals will carry out a clinical trial comparing the effectiveness of its medical canna...
Read ArticleThe number of Australian patients being subscribed medicinal cannabis has risen a gigantic 1,191 per...
Read ArticlePot stock Cann Group (ASX:CAN) has “moved into the commercialisation phase” — but it’s with imported...
Read ArticleCannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the c...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleMGC Pharmaceuticals has surpassed 1,000 prescriptions delivered for its medical cannabis-based produ...
Read ArticleMGC Pharmaceuticals has surpassed 1,000 prescriptions delivered for its medical cannabis-based produ...
Read ArticleCannabis is a high-growth industry with a rapidly changing environment. The companies discussed in t...
Read ArticleMGC Pharmaceuticals has surpassed 600 patients that have prescribed for or will be prescribing for i...
Read ArticleMGC Pharmaceuticals Ltd (ASX: MXC) has reported that the number of patients being prescribed its can...
Read ArticleAgri-tech business Roots Sustainable Agricultural Technologies (ASX:ROO) says its crop-cooling techn...
Read ArticleThe Althea Group Holdings Ltd (ASX: AGH) share price has been a positive performer on Wednesday. In...
Read ArticleIt appears leading Canadian cannabis business Canopy Growth Corp didn’t get the ‘buy low, sell high...
Read Article2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicina...
Read ArticleCannabis industry is composed of ancillary products and services, legal cultivators and producers, c...
Read ArticleThe Althea Group Holdings Ltd (ASX: AGH) share price is on course to end the week on a high. In ear...
Read ArticleSpecial Report: MGC’S strategic focus on building out its global distribution network is starting to...
Read ArticleIt has been a busy day in the Australian cannabis industry with a series of an announcements being...
Read ArticleThis week, the 33 cannabis (and cannabis-adjacent) stocks tracked by Stockhead posted an average wee...
Read ArticleMGC Pharmaceuticals has now passed 200 patients that have prescribed for or will be prescribing for...
Read ArticleSpecial Report: MGC Pharma’s flagship epilepsy drug CannEpil will be the subject of yet another clin...
Read ArticleMGC Pharmaceuticals will carry out a clinical study comparing the effectiveness of its medical canna...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price has pushed higher in morning trade following the...
Read ArticleThe Cann Global Ltd (ASX: CGB) share price has been a big mover on the Australian share market on T...
Read ArticleMGC Pharmaceuticals is collaborating with the Slovenian Institute of Hop Research and Brewing on a l...
Read ArticleMedicinal pot stock Cann Group (ASX:CAN) is planning to go large at its Mildura-based cannabis manuf...
Read ArticleThe increasing use of medical cannabis products has prompted many countries to soften the regulation...
Read ArticleMGC Pharmaceuticals is hoping to overturn legislation that forbids medical cannabis users from drivi...
Read Article‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and th...
Read ArticleThe company is actively progressing towards a listing on the London Stock Exchange in the second hal...
Read ArticleMGC Pharmaceuticals is planning to list on the London Stock Exchange in the second half of the 2019...
Read ArticleSpecial Report: MGC Pharma has significantly boosted its cash position ahead of a big second half of...
Read ArticleRecently, Barbados, a Caribbean country, has introduced the Medicinal Cannabis Industry Act. If pass...
Read ArticleOn Stockhead today, the disconnect between federal and state governments on coal, private equity dea...
Read ArticleThe healthcare industry of Australia is a key contributor in developing the economy. The companies w...
Read ArticleThe legalisation of medical cannabis in southeast Asia is gathering steam with news that Thailand ha...
Read ArticleAustralia has a well-regulated and high-quality health sector, while its medical research and health...
Read ArticleAt time of writing, the share price of MGC Pharmaceuticals Ltd [ASX:MXC] is holding steady at 5.3 ce...
Read ArticleMGC Pharmaceuticals now has 100 patients that have been prescribed or will be prescribed its medical...
Read ArticleMGC Pharmaceuticals will start construction of its large-scale medical cannabis facility in Malta du...
Read ArticleSpecial Report: Making good on its promises, bio-pharma company MGC Pharma has signed a long-term le...
Read ArticleMGC Pharmaceuticals (ASX: MXC) is establishing a key gateway into the potentially lucrative European...
Read ArticleThe MGC Pharmaceuticals Ltd (ASX: MXC) share price could be on the move today after the cannabis co...
Read ArticleThe federal government has taken steps to cut red tape and speed up the granting of licences for Aus...
Read ArticleMGC Pharmaceuticals will sell its nutraceutical products in China through YuShop Global’s online pla...
Read ArticleMedicinal cannabis company Cannvalate is getting its ducks in a row ahead of its planned IPO, streng...
Read ArticleGot 90 seconds? Then listen to MGC Pharmaceuticals co-founder and managing director, Roby Zomer disc...
Read ArticleToday, we hear from Maxim Jacobs, managing partner at New York-based Edison Investment Research. W...
Read ArticleNorth American cannabis stocks have been rocked by scandal lately. Regulatory deadlocks, smaller tha...
Read ArticleGot 90 seconds? Then listen to Edison Investment Research managing partner Maxim Jacobs discuss the...
Read ArticleImpression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a...
Read ArticleThe use of medicinal cannabis is extending, and the developments appear to be favourable for the com...
Read ArticleSponsored Content There may be some hope yet for sufferers of glioblastoma, an extremely aggressive...
Read ArticleMGC Pharmaceuticals’ cannabinoid formulations may hold the key for treating some of the most aggress...
Read ArticleBiopharmaceutical company MGC Pharmaceuticals (ASX: MXC) has completed what it calls “ground-breakin...
Read ArticleSpecial Report: New research from MGC Pharma might hold the key to treating glioblastoma, an extreme...
Read ArticleTaking the cannabis market to the next level, the US is now taking a closer look at the industry’s l...
Read ArticleIs the world progressing at a pace that it would “go green” when it comes to legalizing of cannabis?...
Read ArticleSpecial Report: A strong June quarter has seen a substantial increase in revenue for the European-ba...
Read ArticleThe below-mentioned healthcare stocks have announced significant updates today (i.e., 11th July 2019...
Read ArticleMGC Pharmaceuticals’ revenue for the quarter ended 30 June 2019 has hit $763,000 due to rising order...
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read ArticleDo you know that market enthusiasts believe that legalising cannabis would generate approximately $8...
Read ArticleIn the 19th century, ambitious Brits mused about pushing pianos to one of every five Chinese familie...
Read ArticleThis week the US state of Illinois became the first to pass a bill allowing retail sales of recreati...
Read ArticleThe Althea Group Holdings Ltd (ASX: AGH) share price has started the week with a bang. In early afte...
Read ArticleCannabis finds many applications in the medical field, where it helps in the formulation of drugs to...
Read ArticleThe below-mentioned health care stocks have come up with significant updates today. Let’s take a qui...
Read ArticleMGC Pharmaceuticals has signed a distribution agreement for its medical cannabis products that cover...
Read ArticleShares in medicinal cannabis company Althea (ASX: AGH) found some demand this morning after a promis...
Read ArticleSpecial Report: MGC Pharmaceuticals (ASX:MXC) has signed a new distribution agreement with a German-...
Read ArticleMGC Pharmaceuticals will distribute its medical cannabis products in Brazil under an agreement with...
Read ArticleSpecial Report: MGC Pharmaceuticals is going deep into Brazil, signing a distribution agreement with...
Read ArticleThe market has continued its charge on Wednesday and is trading notably higher this morning. Two com...
Read ArticleMedical cannabis uses the marijuana plant or chemicals extracted from the plant for the treatment of...
Read ArticleMedical cannabis is becoming popular in the pharmaceutical industry, with more and more countries le...
Read ArticleMGC Pharmaceuticals has received a 50% increase in medical cannabis orders from repeat and new presc...
Read ArticleSpecial Report: Following a strong second quarter, MGC Pharma is increasing its market penetration a...
Read ArticleOne area of the share market that is performing better than most on Thursday is the cannabis industr...
Read ArticleDespite IG Markets forcing its users to sell the 19 global pot stocks on its books by 24 May, Austra...
Read ArticleNimble ASX pot-stock MGC Pharmaceuticals (ASX:MXC) this week smashed a pivotal milestone, scoring fu...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
